Results 211 to 220 of about 307,636 (357)
Home‐Based Care Outcomes: Does the Care Provider Matter?
Health Economics, EarlyView.ABSTRACT Long‐term services in the home are predominately provided by family or friends, with a growing proportion of individuals receiving formal care, or paid care by a professional, or a combination of both. However, the relative benefits to the care recipient of who provides the care are largely unknown.
Norma B. Coe +4 more
wiley +1 more source
Journal of General and Family Medicine, Volume 24, Issue 1, Page 3-8, January 2023., 2023 This study qualitatively explored how Japanese medical students think about their future work‐life balance (WLB) using post‐lecture comments, from the perspective of constructivism. For the improvement of WLB among doctors, the necessity of fostering awareness of the nature of WLB in medical school before graduation was shown.
Tomoko Matsui, Machiko Inoue
wiley +1 more source
Analysis of Pelvic Morphology and Birthing Practices:Comparisons of Modern and Prehistoric Humans
The Owl, 2013 Obstetrics has changed drastically with improvements from the scientific community, but there are still many places of the world where modern medicine is underutilized.
Jessica Engel
doaj
JGH Open, Volume 6, Issue 12, Page 894-903, December 2022., 2022 We assessed treatment and cost outcomes for integrated HIV and viral hepatitis testing with ledipasvir/sofosbuvir ± weight‐based ribavirin for 12 weeks in Kyiv, Ukraine. Overall, a sustained virological response (SVR) was achieved in 831 of 868 patients (95.7%).
Sergie Antoniak +24 more
wiley +1 more source
An Analysis of Major Issues for Culturally-Minded Professionals in Women\u27s Health Care [PDF]
, 2019 Women\u27s health care professionals, such as general physicians, obstetricians and gynecologists, midwives, nurses, and doulas, in the US need to be aware of cultural issues and disparities.
Clark, Victoria
core +1 more source
Journal of Hepato-Biliary-Pancreatic Sciences, Volume 30, Issue 1, Page 102-110, January 2023., 2023 Ioka and colleagues present the results of a phase III study comparing gemcitabine and cisplatin plus S‐1 (GCS) with gemcitabine and cisplatin for unresectable or recurrent biliary tract cancer. GCS demonstrated survival benefits and a higher response rate, and could be the new standard chemotherapy for advanced biliary tract cancer.
Tatsuya Ioka +21 more
wiley +1 more source